EZH2 and Familial prostate cancer: Numerous studies suggest that EZH2 is aberrantly overexpressed in several types of cancer, particularly metastasic breast and prostate cancer, and EZH2 overexpression promotes cell proliferation, invasion and metastasis (19–21).